Does Cosentyx (secukinumab) weaken the immune system?
Cosentyx is an immunomodulating medicine, and it can dampen parts of the immune response. It targets interleukin-17A (IL‑17A), a signal that helps drive inflammation and immune activity in diseases like plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. By blocking IL‑17A, Cosentyx reduces inflammatory signaling rather than boosting immune strength.
Because it changes immune signaling, Cosentyx can increase susceptibility to certain infections compared with people not taking an IL‑17 blocker. This is the most common practical way patients experience the effect: not that the immune system becomes “stronger,” but that it becomes more “limited” in specific inflammatory pathways.
What kinds of infections do people worry about on Cosentyx?
The main patient concern with IL‑17A blockers is infection risk, especially infections that depend on inflammatory pathways that IL‑17 supports. People are typically advised to seek medical advice if they develop symptoms of infection (such as fever or persistent worsening infection symptoms) and to discuss their risk factors with their clinician.
Does Cosentyx increase immunity against viruses or bacteria?
No. Cosentyx is not designed to increase general immune protection against infections. Its goal is to reduce abnormal inflammatory activity by blocking IL‑17A. That means it is more accurate to think of Cosentyx as shifting immune activity down in a targeted way, not increasing overall immune defenses.
What this means for vaccination and “immune strength”
Because Cosentyx can affect immune signaling, vaccination timing and vaccine type can matter. In many immunomodulating therapies, clinicians pay attention to whether a vaccine is “live” or “inactivated” and coordinate vaccination plans before starting or during treatment. Patients should ask their prescribing clinician or pharmacist what applies to their situation and vaccine schedule.
How to interpret “immune system” in real terms
If you mean immune strength as “ability to fight infections,” Cosentyx can be associated with higher infection risk. If you mean immune strength as “driving inflammation,” Cosentyx works by reducing that inflammation. In other words, it tends to weaken immune-driven inflammation, not strengthen the immune system overall.